z-logo
open-access-imgOpen Access
Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination
Author(s) -
Michael D. Frakes,
Melissa F. Wasserman
Publication year - 2020
Language(s) - English
Resource type - Reports
DOI - 10.3386/w27579
Subject(s) - scrutiny , ex ante , agency (philosophy) , business , quality (philosophy) , margin (machine learning) , patent office , operations management , actuarial science , public economics , economics , law , computer science , political science , macroeconomics , philosophy , epistemology , machine learning

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here